Nano Magic CEO talks mission for nanotechnology innovation

Video
Conference|Vision Expo East

Nano Magic's Tom Berman discusses the company's origins and mission in creating nanotech-powered solutions.

Following Vision Expo East, Optometry Times®' Alex Delaney-Gesing catchups up with Tom Berman, president/CEO of Nano Magic, as he discusses the company's origins and mission in creating nanotech-powered solutions.

See more Vision Expo East coverage

Recent Videos
EnVision Summit Co-chairs Sherrol Reynolds, OD, FAAO; Katie Rachon, OD, FAAO, Dipl ABO; Jessica Steen, OD, FAAO, Dipl ABO; and Cecelia Koetting, OD, FAAO, Dipl ABO; express excitement for the upcoming conference and why optometrists should attend.
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
Related Content
Conference audience Image credit: AdobeStock/John

Top takeaways from the 2024 meeting of the American Academy of Optometry

Emily Kaiser Maharjan, Assistant Managing Editor
December 16th 2024
Article
VEW 2022: Guess again, your child is NOT too young for contact lenses

VEW 2022: Guess again, your child is NOT too young for contact lenses

Vittorio Mena, OD, MS,;Kassi Jackson Filkins, Editor
September 15th 2022
Podcast
Insertion of contact lens Image credit: AdobeStock/AndreyPopov

What will myopia control look like in 2034?

Hattie Hayes;Carly Lam, PhD, MSc
December 9th 2024
Article
VEW 2022: Concussion management with Dr. Mena

VEW 2022: Concussion management with Dr. Mena

Vittorio Mena, OD, MS,;Kassi Jackson Filkins, Editor
September 15th 2022
Podcast
Glasses on pink backdrop Image credit: AdobeStock/АнатолийСав

A dazzling Vision Expo West pairs showmanship with education and research

Emily Kaiser Maharjan, Assistant Managing Editor;Jordana Joy, Associate Editor
November 28th 2024
Article
Medical profession in PPE in front of AI graphic Image credit: AdobeStock/ipopba

How artificial intelligence is impacting optometry

Vittorio Mena, OD, MS,
November 26th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.